本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Teladoc Health Inc.

6.20
-0.1900-2.97%
盤後6.250.0500+0.81%19:52 EDT
成交量:317.63萬
成交額:1,986.82萬
市值:11.26億
市盈率:-6.25
高:6.40
開:6.37
低:6.17
收:6.39
52周最高:9.89
52周最低:4.40
股本:1.82億
流通股本:1.81億
量比:0.88
換手率:1.76%
股息:- -
股息率:- -
每股收益(TTM):-0.9925
每股收益(LYR):-1.1400
淨資產收益率:-12.99%
總資產收益率:-3.22%
市淨率:0.86
市盈率(LYR):-5.44

資料載入中...

2026/08/14

重要事件披露

Form 8-K - Current report
2026/08/04

重要事件披露

Form 8-K - Current report
2026/07/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/21

重要事件披露

Form 8-K - Current report
2026/04/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors